Analystreport

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was given a new $62.00 price target on by analysts at Nomura. They now have a "sell" rating on the stock.

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview